logo
RFK Jr.'s firing of US immunization committee is worrisome Canadian scientists say

RFK Jr.'s firing of US immunization committee is worrisome Canadian scientists say

Canadian doctors and scientists say Robert F. Kennedy Jr.'s firing of an immunization advisory committee south of the border is worrisome.
On Monday, the US health and human services secretary — a longtime anti-vaccine advocate — said he will appoint new members to the scientific group that advises the Centers for Disease Control and Prevention about vaccination.
Angela Rasmussen, a virologist at the University of Saskatchewan, said Tuesday that the move will foster more false anti-vaccine beliefs, not only in the US but also in Canada.
"It creates a culture in which anti-vaxx beliefs are more accepted and challenged a lot less. And also it creates an environment where there's an alternative to an evidence-based recommendation framework," she said.
Even though Kennedy's new appointments will make vaccine recommendations specific to the United States, any disinformation could also feed vaccine hesitancy among Canadians, Rasmussen said.
"We have a lot of the same anti-vaxx sentiment up here. Certainly this will at the very least empower (that)," she said.
Rasmussen said current measles outbreaks in both countries show the consequences of disinformation that leads to parents not immunizing their children against preventable diseases.
She said Canada could also experience some fallout if the new committee pulls back vaccination recommendations, because manufacturers may cut back on production and that could lead to shortages.
"There's a lot of potential for really, really damaging vaccine access throughout the US and potentially around the world because the US market has a big impact on what vaccine manufacturers are actually going to make and manufacture," she said.
"There's so many ways that this can end up really badly for vaccination in general. And it really causes me a lot of concern."
Rasmussen said the firing of the advisory committee members is just the latest in a series of anti-public health actions Kennedy has taken.
"It's a death by a thousand cuts," said Rasmussen, who is American and moved to Canada during the pandemic to work at the University of Saskatchewan's Vaccine and Infectious Disease Organization.
US President Donald Trump 's administration has already cut billions of dollars in research grants at the National Institutes of Health.
In May, the administration cancelled a contract with mRNA vaccine manufacturer Moderna to develop a vaccine against potential pandemic influenza viruses, including H5N1 avian flu.
"It just seems that there is a top-down approach that views mRNA vaccines in particular — vaccination in general, but mRNA vaccines in particular — with distrust and is trying to dismantle that particular avenue of medical research," said Dr. Jesse Papenburg, a pediatric infectious diseases specialist at Montreal Children's Hospital.
Papenburg, who is a member of Canada's National Advisory Committee on Immunization but was not speaking on its behalf, said although the Moderna contract cancellation and the firing of the US vaccine advisory committee members are two separate actions, they're both concerning as Canada tries to prepare for potential human-to-human transmission of H5N1.
"Both are potentially very dangerous when it comes to America's and the world's ability to respond to emerging infectious diseases for which vaccines could be a useful medical countermeasure," he said.
This report by The Canadian Press was first published June 11, 2025.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr. taps new vaccine advisers days after firing previous panel
RFK Jr. taps new vaccine advisers days after firing previous panel

Global News

time2 hours ago

  • Global News

RFK Jr. taps new vaccine advisers days after firing previous panel

On Wednesday, the head of the U.S. health department, Robert F. Kennedy Jr., appointed eight new members to a vaccine advisory committee from which he abruptly fired all 17 experts in one go earlier this week. He ousted the panel, known as the Advisory Committee on Immunization Practices (ACIP), which was predominantly comprised of practicing physicians with connections to top university medical centres, over claims that divisions among the group were undermining public trust in vaccinations. 'The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any vaccine,' he wrote in an announcement, published in The Wall Street Journal on Monday. On Wednesday, he tapped new members to sit on the committee, among them a scientist who researched mRNA vaccine technology and became a beloved conservative commentator for his criticisms of COVID-19 vaccines, a leading critic of pandemic-era lockdowns, and a professor of operations management. Story continues below advertisement On Monday, I took a major step towards restoring public trust in vaccines by reconstituting the Advisory Committee for Immunization Practices (ACIP). I retired the 17 current members of the committee. I'm now repopulating ACIP with the eight new members who will attend ACIP's… — Secretary Kennedy (@SecKennedy) June 11, 2025 On Tuesday, before he announced his picks, Kennedy said: 'We're going to bring great people onto the ACIP panel – not anti-vaxxers – bringing people on who are credentialed scientists,' according to the Associated Press. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Meet the new appointees Vicky Pebsworth is a regional director for the National Association of Catholic Nurses and has been listed as a board member and volunteer director for the National Vaccine Information Center, a group widely considered to be a leading source of vaccine misinformation. Dr. Robert Malone is a former mRNA researcher who emerged as a close adviser to Kennedy during the measles outbreak. He also runs a wellness institute and a popular conspiracy-heavy blog, which gained popularity during the COVID-19 pandemic as he shared unsubstantiated claims around the outbreak and the vaccines, including that they caused AIDS. 2:10 Health Matters: RFK Jr. ousts vaccine advisory committee He has promoted unproven and alternative treatments for measles and COVID-19, and has claimed that millions of Americans were hypnotized into getting COVID-19 shots. Story continues below advertisement Malone told The Associated Press he will do his best 'to serve with unbiased objectivity and rigor.' Dr. Martin Kulldorff, a biostatistician and epidemiologist, was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm. Dr. Joseph R. Hibbeln formerly headed a National Institutes of Health group focused on nutritional neurosciences and how nutrition affects the brain, including the potential benefits of seafood consumption during pregnancy. Retsef Levi is a professor of operations management at the Massachusetts Institute of Technology who studies business supply chains, logistics, pricing optimization, and health care management. He also claimed in 2023 that COVID-19 vaccines were ineffective and dangerous despite evidence that they saved millions of lives. Dr. James Pagano is an emergency medicine physician from Los Angeles. Dr. Michael Ross, a Virginia-based OBGYN, previously served on a CDC breast and cervical cancer advisory committee. He is described as a 'serial CEO and physician leader' in a bio for Havencrest Capital Management, a private equity investment firm where he is an operating partner. Dr. Cody Meissner is a professor of pediatrics at the Geisel School of Medicine at Dartmouth and a nationally recognized expert in pediatric infectious diseases and vaccine policy. He has previously served as a member of both ACIP and the Food and Drug Administration's vaccine advisory panel. — Story continues below advertisement — With files from The Associated Press

CCRAN Announces Its Third Annual Pan-Tumour Biomarkers Conference: Transforming Cancer Care for Patients Through Precision Medicine, Policy, and Partnerships
CCRAN Announces Its Third Annual Pan-Tumour Biomarkers Conference: Transforming Cancer Care for Patients Through Precision Medicine, Policy, and Partnerships

Cision Canada

time8 hours ago

  • Cision Canada

CCRAN Announces Its Third Annual Pan-Tumour Biomarkers Conference: Transforming Cancer Care for Patients Through Precision Medicine, Policy, and Partnerships

TORONTO, /CNW/ - The Colorectal Cancer Resource & Action Network (CCRAN) proudly announces its third annual Pan-Tumour Biomarkers Conference, taking place virtually June 19 - 20, 2025. As the role of comprehensive genomic profiling (CGP) and biomarker-driven treatments become increasingly vital in cancer care, this event reaffirms CCRAN's position at the forefront of Canada's precision medicine movement. The 2025 Conference arrives at a critical time. With provinces and territories working to align clinical innovation with system delivery, this year's event brings together leaders across healthcare, policy, research, industry, and patient communities to explore what it will take to embed comprehensive genomic profiling (CGP) into the fabric of cancer care - consistently, efficiently, and with long-term sustainability in mind. With a curated agenda centered on health system readiness, policy development and advocacy strategies, the Conference will drive widespread integration of genomic testing, specifically CGP, across cancer care in Canada. From laboratory infrastructure to funding models and clinical adoption, speakers will explore both the science and systems behind matching patients with the most effective treatments for their unique cancer profile. A key highlight of the 2025 Conference is the keynote presentation by the Conference Board of Canada, wherein a groundbreaking cost-benefit analysis will be unveiled to showcase the transformative value of CGP across five tumour types – lung, colorectal, breast, pancreatic and prostate. This study will demonstrate not only the substantial return on investment in modernizing Canada's testing landscape, but more importantly, quantify the profound benefits to patients, including improved survival outcomes, enhanced quality of life, reduced treatment toxicity, and faster access to targeted therapies. This critical data will inform policy decisions and provide compelling evidence for healthcare leaders to accelerate the adoption of precision medicine, ultimately ensuring Canadian cancer patients receive the most effective, personalized care possible. The event also builds on CCRAN's continued efforts to mobilize support for biomarker-driven cancer care through education, policy dialogue, and cross-sector partnerships. CCRAN has played a vital role in amplifying the urgency of public access to biomarker testing and is also helping to align national conversations around the need for timely, standardized, and publicly funded diagnostics. " Precision oncology must be accessible to every Canadian metastatic cancer patient, regardless of geography or circumstance," said Filomena Servidio-Italiano, President & CEO, CCRAN. " This Conference brings together the expertise and momentum required to overcome barriers and chart a clear path forward for advancing genomic testing in Canada's cancer care system." The Conference is designed for healthcare professionals, health system administrators, researchers, policy leaders, patients, caregivers, and all those invested in building a more personalized and equitable future for cancer care in Canada. CCRAN extends its heartfelt gratitude to our premier partners - Merck, AstraZeneca, Roche, Johnson & Johnson - for their unwavering commitment to advancing equitable access to precision medicine in Canada. The organization also expresses its sincere appreciation to the balance of the Conference sponsors as well as the dedicated patient advocacy group partners whose collaboration ensures that the patient voice remains at the heart of every initiative. Registration is free. All sessions will be hosted virtually and made available for post-event viewing. To register and view the full agenda, visit: About CCRAN: The Colorectal Cancer Resource & Action Network (CCRAN) is a national, patient-focused advocacy group that champions the health and well-being of Canadians touched by colorectal cancer, and others at risk of developing the disease. They provide support, education, and advocacy to patients (and their caregivers) to help improve patients' quality of life, as well as their longevity.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store